Roundtable Discussion: Evaluating the Need for Biomarker & Patient Selection Tools in an Increasingly Busy ADC Field
- What is the current need and appetite for ADC biomarker development and patient selection strategies heading into 2025?
- Discussing the different methodologies across machine learning and digital pathology to quantify IHC-derived ADC target expression
- Addressing the challenges and opportunities of biomarker analysis to select patient populations to benefit from specific ADCs